 controlled clinical trial effect calcium channel blocker progression coronary atherosclerosis calcium channel blockers progression coronary atherosclerosis patients age years coronary artery segments random month coronary arteriography double-blind therapy placebo nicardipine mg times Coronary events deaths myocardial infarctions unstable anginas nicardipine patients placebo patients NS months coronary arteriography patients Progression worsening diameter stenosis lesions nicardipine patients lesions placebo patients NS Ninety-two nicardipine patients placebo patients progression sites NS Regression improvement diameter stenosis lesions overall significant intergroup difference patients stenoses less first study minimal lesions nicardipine patients placebo patients subgroup minimal lesions nicardipine patients minimal lesions placebo patients stepwise logistic-regression analysis systolic blood pressure change systolic blood pressure baseline months progression minimal lesions blood pressure reduction beneficial action nicardipine results nicardipine effect advanced coronary atherosclerosis progression minimal lesions